These data, together with a previous report that AKR1B10 inhibition results in apoptosis of tumor cells, in which the level of cellular phospholipids was decreased significantly14, prompted us to consider S1P as the potential molecule downstream of AKR1B10 that is involved in AKR1B10’s oncogenic function. The gene discussed is AKR1B10; the disease is neoplasm.